It's a fact, Arena has been milking debt structure, dilutions, warrants, and all possible ways to remain solvent for the past 15 years or more. Their comes a point as they have made drug developments, that the cow they have milked for funding needs can no longer support the future funding development needs of the discoveries they have developed to date. In short, all the good work they have developed to this point, now requires far more funding than ever before. At this point, the pipeline is a liability for funding need to develop it.....back to my point, the funding cow they have been milking (et. all resources) has quit giving milk, nor can it give enough to feed the needs going forward. It simply takes a much bigger company with ample funds, a solid balance sheet, along with R&D money in the bank. Arena is borrowing, or diluting shares for R&D funding, it's not from money in the bank, and they cannot be profitable for the mid term future.
Financially they are not in a good position, nor have they been for several years. There simply is not enough revenue from Belviq to sustain their general operating needs, let alone continued product development. The company is at a crossroad......more dilution to keep running or sell to a larger entity. Cash flow vs operating funds have been a constant need for the last 10 years to remain solvent. Facts are we have a fat cat salary, high labor payroll, many dilutions, and various debt structures along the way to remain solvent. Each time the shareholders took it on the chin. The future funding needs are very heavy for anymore product development unless someone else carries the ball forward giving Arena a small piece of future rewards, they will probably still remain needing cash flow. Those that can't see this financial disaster are blind, and the CEO, management in general are not being frank with the shareholders as to what must take place to sustain the company. We need a change of leadership, because what we have now has lost the confidence of Wall Street, the investment community, and in general other interest for partnerships to join hands. More company's have let go of past deals rather than remain until the end with Arena. This all rest with Jack Leif and failed leadership both financially, and for partnership deals.
Yep, it's true. Spencer has always put forth a word of caution when discussing ARNA. He was dead right about small pharma with new products and the long road to success. I wish I would have listened to him as he outlined the pitfalls over time. I think he would even admit he got snookered a little by Jack"O" and company.
We have seen this before......buy low and sell high. None hold shares long, and we could go up $0.75 to $1.00 just before they sell. I'll get out with them if it happens.....first or last guy out the door I am all gone at $
Moved it to $4.42 as it tanked.....no fill, I am losing some money at $4.50 and I hate that, but can make up the difference on a dividend stock buy ex-date coming soon.
Next big buy is adding more SHLX (Shell Midstream Partners) A drop down of assets coming soon from big daddy parent Shell. Share value will increase just like PSXP did with Phillips 66 over the last two years from the IPO it went up 2.5 X's
Don't be a fool......the other countries won't amount to what the USA is doing now, and ARNA needs three times the script current count to keep things afloat, yet even make a profit perhaps. Easai has already bailed out in the USA, do you think they will hire a dedicated sales force in any other region......nope you dope!
Tide is going out......must be low tide time. That's my story and I am sticking to it. Jack is a stand-up guy, I love him, and love this country. It's just the tide? I have been trying to sell for the last few days, and can't get $4.45 to move on and leave you guy's to fight for a winner. This DOG can't swim, fetch, or sniff out my sell price. The company is drowning, or you might just see some insider option buy's as it tanks again before they throw us a bone and run it up to sell their shares AGAIN.
I hate being a sucker one more time.
Folks have been saying that for several years now, me included. Hope is lost as long as Jack"O" is in control. Here we sit scraping at the bottom again.........what's new? Nothin!
This dog don't hunt! Can't even get a fill to sell at $4.42 today with the market UP. I would like to get out at $4.50 but ARNA is a dog today, and can't sniff out my price.
I expect two things......#1 thing, the market makers will drop the price to trigger the majority of stop losses set in place to get hold of those shares on the cheap. #2 thing, It will close above $8.25 by days end.
I am placing two market orders at the open (1) 0.15 cents and (2) 0.30 cents below todays closing price to catch the stop loss wipeout tricksters and hope I get a fill if they take it down.
Do the pieces of the puzzle start to fit now? Last conference call less than expected earnings and a sharp drop in share prices leading up to that event. Insiders take advantage of low pps and buy, buy, buy almost all the available shares across their ranks. Options or not, they still had to dig in their pocket to purchase. OSUR starts climbing back up a few days before they ring the opening bell at NASDAQ one day prior to this coming announcement the stock jumps +23.91% with no news posted yet, these same exec's will all be at the event tomorrow. After hours trading is brisk, with a high of $7.55 and holding $7.45.
“(1) IN GENERAL.—In carrying out this section, and not later than 60 days after the date of the enactment of the Viral Hepatitis Testing Act of 2015, the Secretary shall, in consultation with the Assistant Secretary for Health, the Director of the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the Substance Abuse and Mental Health Services Administration, the Office of Minority Health, the Indian Health Service, other relevant agencies, and nongovernment stakeholder entities, establish and support public-private partnerships that facilitate the surveillance, education, screening, testing, and linkage to care programs authorized by this section.
This brief section directs the Sec.of Health to establish public and private partnerships and the bill provides funding to do this. This is what the announcement is all about on Tuesday 5/19/2015.... H.R. 1101 The Viral Hepatitis Act of 2015. Tuesday is the launch of this program. Now guess who has the only FDA approved test........OraSure Tech. (OSUR)
Section from HR 1101 for Hep C programs, directive for public and private partnerships to the Sec. of Health“ in HR 1101..........SCREENING & TESTING are included in this directive by congress. **(1) IN GENERAL.—In carrying out this section, and not later than 60 days after the date of the enactment of the Viral Hepatitis Testing Act of 2015, the Secretary shall, in consultation with the Assistant Secretary for Health, the Director of the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the Substance Abuse and Mental Health Services Administration, the Office of Minority Health, the Indian Health Service, other relevant agencies, and nongovernment stakeholder entities, establish and support public-private partnerships that facilitate the surveillance, education, screening, testing, and linkage to care programs authorized by this section.